132 related articles for article (PubMed ID: 19832713)
1. Pharmacokinetics of gentamicin in critically ill patients: pilot study evaluating the first dose.
Gonçalves-Pereira J; Martins A; Póvoa P
Clin Microbiol Infect; 2010 Aug; 16(8):1258-63. PubMed ID: 19832713
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic outcomes of a simplified, weight-based, extended-interval gentamicin dosing protocol in critically ill neonates.
Hoff DS; Wilcox RA; Tollefson LM; Lipnik PG; Commers AR; Liu M
Pharmacotherapy; 2009 Nov; 29(11):1297-305. PubMed ID: 19857147
[TBL] [Abstract][Full Text] [Related]
3. The effects of age and chemotherapy on gentamicin pharmacokinetics and dosing in pediatric oncology patients.
Ho KK; Bryson SM; Thiessen JJ; Greenberg ML; Einarson TR; Leson CL
Pharmacotherapy; 1995; 15(6):754-64. PubMed ID: 8602384
[TBL] [Abstract][Full Text] [Related]
4. Suboptimal aminoglycoside dosing in critically ill patients.
Rea RS; Capitano B; Bies R; Bigos KL; Smith R; Lee H
Ther Drug Monit; 2008 Dec; 30(6):674-81. PubMed ID: 19057371
[TBL] [Abstract][Full Text] [Related]
5. Once-daily gentamicin dosing in children with febrile neutropenia resulting from antineoplastic therapy.
Inparajah M; Wong C; Sibbald C; Boodhan S; Atenafu EG; Naqvi A; Dupuis LL
Pharmacotherapy; 2010 Jan; 30(1):43-51. PubMed ID: 20030472
[TBL] [Abstract][Full Text] [Related]
6. Otoacoustic emission screen results in critically ill neonates who received gentamicin in the first week of life.
Cooper AC; Commers AR; Finkelstein M; Lipnik PG; Tollefson LM; Wilcox RA; Hoff DS
Pharmacotherapy; 2011 Jul; 31(7):649-57. PubMed ID: 21923451
[TBL] [Abstract][Full Text] [Related]
7. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
[TBL] [Abstract][Full Text] [Related]
8. Impact of altered aminoglycoside volume of distribution on the adequacy of a three milligram per kilogram loading dose. Critical Care Research Group.
Dorman T; Swoboda S; Zarfeshenfard F; Trentler B; Lipsett PA
Surgery; 1998 Jul; 124(1):73-8. PubMed ID: 9663254
[TBL] [Abstract][Full Text] [Related]
9. Extended-interval gentamicin: population pharmacokinetics in pediatric critical illness.
Lopez SA; Mulla H; Durward A; Tibby SM
Pediatr Crit Care Med; 2010 Mar; 11(2):267-74. PubMed ID: 19770786
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetics of a single daily intramuscular dose of gentamicin in children with severe malnutrition.
Seaton C; Ignas J; Muchohi S; Kokwaro G; Maitland K; Thomson AH
J Antimicrob Chemother; 2007 Apr; 59(4):681-9. PubMed ID: 17347177
[TBL] [Abstract][Full Text] [Related]
11. Dose derivation of once-daily dosing guidelines for gentamicin in critically ill pediatric patients.
Zakova M; Pong S; Trope A; Atenafu EG; Papaioannou V; Bitnun SA; Richardson S; Schwartz S; Cox P; Parshuram C; Seto W
Ther Drug Monit; 2014 Jun; 36(3):288-94. PubMed ID: 24695354
[TBL] [Abstract][Full Text] [Related]
12. [Individualized monitoring of the therapy with gentamycin using pharmacokinetic methods. Which method to choose?].
Carvalho A; Fonseca C; Falcão F; Pereira TA; Freitas O; Parrinha A; Costa M; Rodrigues MJ; Ceia F; Luís AS
Acta Med Port; 1996; 9(7-9):187-95. PubMed ID: 9005695
[TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetics of gentamicin in hospitalized patients receiving once-daily dosing.
Xuan D; Nicolau DP; Nightingale CH
Int J Antimicrob Agents; 2004 Mar; 23(3):291-5. PubMed ID: 15164971
[TBL] [Abstract][Full Text] [Related]
14. Determinants of gentamicin concentrations in critically ill patients: a population pharmacokinetic analysis.
Hodiamont CJ; Juffermans NP; Bouman CS; de Jong MD; Mathôt RA; van Hest RM
Int J Antimicrob Agents; 2017 Feb; 49(2):204-211. PubMed ID: 28038961
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic basis for the use of extended interval dosage regimens of gentamicin in neonates.
Lanao JM; Calvo MV; Mesa JA; Martín-Suárez A; Carbajosa MT; Miguelez F; Domínguez-Gil A
J Antimicrob Chemother; 2004 Jul; 54(1):193-8. PubMed ID: 15150171
[TBL] [Abstract][Full Text] [Related]
16. Eight years' experience of an extended-interval dosing protocol for gentamicin in neonates.
Begg EJ; Vella-Brincat JW; Robertshawe B; McMurtrie MJ; Kirkpatrick CM; Darlow B
J Antimicrob Chemother; 2009 May; 63(5):1043-9. PubMed ID: 19299469
[TBL] [Abstract][Full Text] [Related]
17. Gentamicin pharmacokinetics in adults with bacterial endocarditis.
Rosell-Rovira ML; Pou-Clavé L; García-Beltran L; Pascual-Mostaza C
Am J Hosp Pharm; 1994 Jun; 51(11):1429-32. PubMed ID: 7942877
[TBL] [Abstract][Full Text] [Related]
18. Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin.
Hermida J; Tutor JC
Ther Drug Monit; 2006 Jun; 28(3):326-31. PubMed ID: 16778715
[TBL] [Abstract][Full Text] [Related]
19. Ciprofloxacin pharmacokinetics in critically ill patients: a prospective cohort study.
van Zanten AR; Polderman KH; van Geijlswijk IM; van der Meer GY; Schouten MA; Girbes AR
J Crit Care; 2008 Sep; 23(3):422-30. PubMed ID: 18725050
[TBL] [Abstract][Full Text] [Related]
20. Single intravenous and multiple dose pharmacokinetics of gentamicin in healthy llamas.
Lackey MN; Belknap EB; Greco DS; Fettman MJ
Am J Vet Res; 1996 Aug; 57(8):1193-9. PubMed ID: 8836374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
